Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, this week announced the pricing of its underwritten public …
Read More WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, this week announced that it intends to offer and …
Read More
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, announced that it has entered into a definitive …
Read More
EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH) on Friday announced the closing of its previously announced underwritten public offering of 15,333,332 shares of its common stock, including 1,999,999 shares …
Read More EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug …
Read More
VALLEY FORGE, PA — AmerisourceBergen Corporation (NYSE: ABC) recently announced the closing of this week’s public offering of $1,525,000,000 aggregate principal amount of its 0.737% Senior Notes due March 15, …
Read More
MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) recently announced that it has closed the previously announced registered direct offering for the sale of an aggregate of 3,000,000 shares of its …
Read More MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that it has entered into a definitive agreement with institutional and …
Read More MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, announced …
Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from …
Read More